相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers
Han-Mo Chiu et al.
GUT (2021)
Using digital twins in viral infection
Reinhard Laubenbacher et al.
SCIENCE (2021)
Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models
Paulina Wieszczy et al.
BMJ OPEN (2021)
Mapping genomic and epigenomic evolution in cancer ecosystems
Toshikazu Ushijima et al.
SCIENCE (2021)
Modeling the overdetection of screen-identified cancers in population-based cancer screening with the Coxian phase-type Markov process
Amy Ming-Fang Yen et al.
STATISTICS IN MEDICINE (2020)
Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach
Thanya Pathirana et al.
BMJ OPEN (2019)
Estimation of overdiagnosis by detection to incidence ratio in cancer screening
Matti Hakama et al.
JOURNAL OF MEDICAL SCREENING (2019)
Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study
Eva Lykke Toft et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2019)
A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control
Boris Kovatchev
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population
Theodore R. Levin et al.
GASTROENTEROLOGY (2018)
Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement
David C. Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia
Jeroen J. van den Broek et al.
MEDICAL DECISION MAKING (2018)
Nonbleeding Adenomas: Evidence of Systematic False-Negative Fecal Immunochemical Test Results and Their Implications for Screening Effectiveness-A Modeling Study
Miriam P. van der Meulen et al.
CANCER (2016)
Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis
Nicolien T. van Ravesteyn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis
Nicolien T. van Ravesteyn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test
Manuel Zorzi et al.
GUT (2015)
The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings
Salah H. Elsafi et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2015)
Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits
Iris Lansdorp-Vogelaar et al.
ANNALS OF INTERNAL MEDICINE (2014)
A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over-detection
Grace Hui-Min Wu et al.
BIOMETRICAL JOURNAL (2012)
Reactive Oxygen Species Induced by Bile Acid Induce Apoptosis and Protect Against Necrosis in Pancreatic Acinar Cells
David M. Booth et al.
GASTROENTEROLOGY (2011)
Effect of Baseline Breast Density on Breast Cancer Incidence, Stage, Mortality, and Screening Parameters: 25-Year Follow-up of a Swedish Mammographic Screening
Sherry Yueh-Hsia Chiu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
The Case for Early Detection of Melanoma
Jason K. Rivers et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2010)
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Gerrit Draisma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer
E. Lindholm et al.
BRITISH JOURNAL OF SURGERY (2008)
Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends
Donatello Telesca et al.
BIOMETRICS (2008)
Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia
N. Pashayan et al.
BRITISH JOURNAL OF CANCER (2006)
Overdiagnosis in early detection programs
O Davidov et al.
BIOSTATISTICS (2004)
Estimation of sojourn time in chronic disease screening without data on interval cases
THH Chen et al.
BIOMETRICS (2000)
分享论文
